A graph-based method for associating sequence variation with traits using short-read genome sequencing data, and shows that it captures complex forms of genetic variation missed by other methods, suggest that integration of pangenomic methods into human genetic studies will improve trait association and genomic prediction at a meaningful subset of genes.
Abstract
The Human Pangenome Reference Consortium has generated 462 open-access reference genomes and a variation graph that represents differences among them, providing a substrate for pangenome-based analysis methods that overcome the longstanding limitation of comparing all genomic data to a single linear reference. A key unresolved question is the extent to which these approaches can improve trait mapping. We investigate this using the genetics of gene expression variation as a model. We developed a graph-based method (EdgeDepth) for associating sequence variation with traits using short-read genome sequencing data, and show that it captures complex forms of genetic variation missed by other methods. We evaluated trait mapping performance using 430 samples with deep RNA-seq data, and found that pangenomic methods enable the detection of expression quantitative trait loci involving multiallelic indels and structural variants, leading to increased power at a subset of genes. These include 812 genes (7.9% of total) with ≥20% improvement in statistical significance relative to the 1000 Genomes Project callset, and 185 (1.8%) with a 50% improvement, 10 of which are candidates to explain prior GWAS results. Notably, these analyses implicate GBAP1 pseudogene copy number as a causal factor in Crohn’s disease, likely via miRNA-mediated regulation of GBA1, which explains prior GWAS results based on flanking SNPs. The inclusion of pangenome-specific variation also improved the performance of gene expression prediction models, with median variance explained increasing from 10.1% to 12.5%, and 14.6% of genes showing significant improvement (Δr2>0.05). Taken together, these results suggest that integration of pangenomic methods into human genetic studies will improve trait association and genomic prediction at a meaningful subset of genes.
High-fidelity pangenome graphs are constructed by integrating both assembly-based and whole-genome sequencing (WGS) derived SV catalogs and provide novel insights into the SV landscape and its contribution to gene regulation, underscoring its importance in cattle genetics and genomics.
This work describes the full spectrum of genetic variation and shows that while 99% of the variants between any two genomes are single base-pair substitutions, 88% of the euchromatic variant base pairs are SVs, including insertions, deletions, duplications, and inversions.
J. Lin, J. Gustafson, J. Wertz et al.· medRxiv· 0 citations
The Human Pangenome Reference Consortium’s (HPRC) Release 2 (HPRC2) is presented, an openly available, second phase pangenome that is an approximately fivefold expansion in genome number over HPRC Release 1 (HPRC1) and measurable improvement in genome completeness, contiguity, and accuracy.
Julian K. Lucas, Prajna Hebbar, Wen-Wei Liao et al.· bioRxiv· 6 citations
Purpose We introduce GraNPA, standing for Graph Node-Phenotype Association, a method performing a GWAS-like analysis on a pangenome variation graph (PVG) built using a small number of individual genome sequences, without the need for additional population materials or kinship information for qualitative phenotypes. Thi...
Camille Carrette, François Sabot, Cédric Muller· bioRxiv· 0 citations
Panvar is a tool developed to integrate existing software and resources to perform GWAS and fine-mapping in one seamless step and seeks to bridge the gap between GWAS and gene speeding up an important step of quantitative genetic studies.
Collin Luebbert, Rijan R. Dhakal, Phillip Ozersky et al.· bioRxiv· 0 citations
This work provides a foundation for applications that link epigenome variation to gene expression in human cells, by benchmarking methods on a per-gene basis, illustrating their use in a disease context and making trained models available to the community.
Fatemeh Behjati Ardakani, Shamim Ashrafiyan, Laura Rumpf et al.· Genome Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.